10.22.25 -- Advance Cell Culture With Optimized Media And Scalable Bioprocessing For Viral Vector And Therapeutic Production

Join life sciences experts and global regulators this 9–10 December for the 2025 ISPE Pharma 4.0™ Conference in Barcelona, Spain, or virtually. This year's agenda spotlights how innovative enabling technologies including AI, machine learning, virtual and augmented reality, industrial internet of things, GxP cloud platforms, robotics, advanced modeling, and automation, are addressing key challenges like drug shortages and improving product availability. LEARN MORE

HEK293 cells are commonly used in the production of biopharmaceuticals. Explore comprehensive, all-in-one solutions designed to support high-density suspension culture.

Discover how settle-based media exchange can streamline your cell culture workflow, reduce cell stress, and improve growth outcomes without the need for centrifugation or complex handling.

Uncover a new genetic engineering medium that boosts siRNA transfection in MSCs to enable more precise gene modulation and advance cell- and vesicle-based therapies.

PHCbi's high-heat sterilization CO2 incubator offers advanced contamination protection while streamlining laboratory operations and helping reduce environmental impact.

Monitor in real-time and control your glucose and lactate concentrations during cell culture and fermentation to achieve process efficiency and optimal productivity.

Examine how a chemically defined viral feed can boost AAV titers by up to 8-fold, supporting multiple serotypes and both suspension and adherent HEK293 cell lines, simplifying scalability.

See how seed train intensification can streamline cell culture scale-up, reduce timelines, and enhance consistency while enabling more efficient use of your cell banks and greater flexibility.

Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture, allowing for longer run times, higher product yields, and reduced costs. 

Media selection is key to CAR-T cell success. Find out how a serum-free, xeno-free medium boosts transduction efficiency, maintains quality, and streamlines the path to clinical scale-up.

Boost your CHO-K1 GS cell culture with a two-part feed system that delivers chemically defined, animal origin-free formulations for consistency and compliance.